A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : RAI / rapid-acting insulin

[Related PubMed/MEDLINE]
Total Number of Papers: 13
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   RAI  (>> Co-occurring Abbreviation)
Long Form:   rapid-acting insulin
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2018 Approaches to rapid acting insulin intensification in patients with type 2 diabetes mellitus not achieving glycemic targets. T2DM
2018 Improving postprandial hyperglycemia in patients with type 2 diabetes already on basal insulin therapy: Review of current strategies. GLP-1, PPG, RAs, T2D
2018 Predictors and Clinical Outcomes of Treatment Intensification in Patients With Type 2 Diabetes Uncontrolled on Basal Insulin in a Real-World Setting. CI, GLP-1RA, OR, T2D
2017 Basal insulin treatment intensification in patients with type 2 diabetes mellitus: A comprehensive systematic review of current options. DPP, FPG, GLP-1RAs, PPG, SGLT2
2017 COMPARING CLINICAL OUTCOMES AND COSTS FOR DIFFERENT TREATMENT INTENSIFICATION APPROACHES IN PATIENTS WITH TYPE 2 DIABETES UNCONTROLLED ON BASAL INSULIN: ADDING GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONISTS VERSUS ADDING RAPID-ACTING INSULIN OR INCREASING BASAL INSULIN DOSE. BI, GLP-1RA
2017 Economic outcomes with the conversion of insulin delivery methods in hospitals. CUD, FS, IPS, RSFH
2017 Persistence with rapid-acting insulin and its association with A1C level and severe hypoglycemia among elderly patients with type 2 diabetes. T2D
2017 Safety and efficacy of a glucagon-like peptide-1 receptor agonist added to basal insulin therapy versus basal insulin with or without a rapid-acting insulin in patients with type 2 diabetes: results of a meta-analysis. CI, GLP-1RAs, T2D
2016 A novel option for prandial insulin therapy: inhaled insulin. HCPs, OADs, T2D
10  2016 Rapid Acting Insulin Use and Persistence among Elderly Type 2 Diabetes Patients Adding RAI to Oral Antidiabetes Drug Regimens. RAIp
11  2015 Adding Rapid-Acting Insulin or GLP-1 Receptor Agonist to Basal Insulin: Outcomes in a Community Setting. GLP-1, T2DM
12  2013 Real world outcomes of adding rapid-acting insulin versus switching to analog premix insulin among US patients with type 2 diabetes treated with insulin glargine. PMX, T2DM
13  2006 Mixing rapid-acting insulin analogues with insulin glargine in children with type 1 diabetes mellitus. DKA, HbA1c, IG